The sutures market is estimated to be valued at USD 4.62 Bn in 2025 and is expected to reach USD 8.19 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.5% from 2025 to 2032.
To learn more about this report, Download Free Sample
The global sutures market is expected to witness significant growth over the forecast period. This is attributed to rising number of surgical procedures worldwide owing to the increasing incidence of chronic diseases and accidents. Additionally, increasing priority on wound management to reduce surgical site infections and faster recovery are further augmenting the demand for sutures. Moreover, growing focus on R&D activities to develop advanced products is also contributing to the sutures market growth.
|
Current Event |
Description and its Impact |
|
Technological Advancement in Smart and Bio-Integrated Sutures |
|
|
Regulatory Harmonization and Quality Standard Evolution |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The sutures market is undergoing a transformative phase, driven by cutting-edge research and technological innovation aimed at enhancing surgical outcomes and patient safety.
In terms of type, the absorbable sutures segment is anticipated to hold 56.4% of the market share in 2025. Absorbable sutures are gradually becoming the standard of care as they overcome key limitations of non-absorbable sutures such as needing removal post-surgery. The inherent property of absorbable sutures to dissolve naturally inside the body relieves patients from the trauma of suture removal and risk of wound site infection associated with it. This reduces postoperative pain and recovery time for patients. Moreover, absorbable sutures such as catgut and polyglycolic acid dissolve and degrade harmlessly without causing any inflammatory response.
For instance, in July 2025, Corza Medical announced the expansion of its Onatec ophthalmic suture portfolio, enhancing its offerings with advanced absorbable and non-absorbable options. Designed for precision in delicate eye surgeries, the new range includes materials like polyglycolic acid and polyglactin 910, aligning with the growing demand for sutures that promote healing while minimizing patient discomfort.
In terms of application, the general surgeries segment projected to account for greatest share of the market in 2025, due to the consistently high volume of procedures such as appendectomies, hernia repairs, and wound closures performed across healthcare facilities worldwide. These surgeries are routine yet essential, requiring reliable suture materials for effective tissue approximation and healing. Both absorbable and non-absorbable sutures are widely used in these procedures, depending on the surgical site and healing requirements. The broad scope and frequency of general surgical interventions make this segment a key driver of suture demand, reinforcing its leading position in the market.
For instance, in October 2025, Mesh Suture Inc. secured key regulatory approvals for its DuraMesh™ technology, paving the way for global adoption. Designed for general surgeries, DuraMesh™ combines traditional suture handling with mesh reinforcement to enhance tissue integration and reduce complications. The approvals mark a significant step in expanding access to advanced wound closure solutions worldwide.
In terms of filament type, the monofilament sutures segment is expected to hold the largest share of the market in 2025. Their smooth surface and single-strand structure significantly reduce tissue drag and the risk of infection, making them especially suitable for delicate procedures such as cardiovascular and plastic surgeries. These sutures offer enhanced handling and minimal trauma, which aligns with the growing preference for minimally invasive techniques and improved patient outcomes.
For instance, in February 2025, Meril unveiled new surgical products for its cardiovascular portfolio, including monofilament polypropylene sutures designed for precision and durability. These sutures offer high tensile strength and minimal tissue reactivity, making them ideal for complex cardiac procedures. The launch reinforces Meril’s commitment to advancing cardiovascular care with innovative, high-performance surgical solutions.
In terms of end user, the hospital segment is expected to capture the highest share of the market in 2025, due to their central role in performing the majority of surgical procedures worldwide. Equipped with advanced infrastructure and comprehensive surgical capabilities, hospitals benefit from bulk procurement strategies and access to a wide range of suture types and technologies. Their dominance is further reinforced by the increasing number of inpatient surgeries and the integration of specialized departments that require tailored suture solutions.
For instance, in May 2025, Applied Medical launched two innovative suture-passing instruments, Rhapso™ and Gemini™, designed to enhance precision in minimally invasive surgeries. Rhapso™ offers intuitive needle-forward control, while Gemini™ features a dual-arm mechanism for versatile suture management. These tools aim to improve surgical efficiency and outcomes in hospital operating rooms worldwide.
To learn more about this report, Download Free Sample
North America has emerged as the largest regional market for sutures, accounting for over 38.4% of the market share. The strong industry presence of major players such as Ethicon (part of Johnson & Johnson) and Medtronic in countries like the U.S. and Canada has helped North America gain dominance in the sutures space. Additionally, sophisticated healthcare infrastructure and expenditure on surgical procedures have sustained the demand for advanced suture devices and techniques in this region over the years. With the region continuing to adopt minimally invasive surgeries at a robust pace, the utilization of sutures is expected to remain high given their indispensable usage in closing surgical incisions or wounds.
For instance, in September 2025, SutureTech received FDA 510(k) clearance for its advanced suture technology, marking a major milestone in surgical innovation. The approval enables broader clinical use and supports safer, more efficient wound closure. This regulatory achievement positions SutureTech to expand its presence in hospitals and surgical centers across the U.S. and globally.
Among all regions, Asia Pacific has illustrated robust expansion and has cemented its position as the fastest growing market for sutures. Countries like India, China, Japan, and South Korea are driving the sutures market growth in Asia Pacific. The hospital infrastructure and healthcare systems are rapidly strengthening in the developing Asian countries, thereby supporting an increase in the number of surgeries annually. This has provided the necessary launchpad for suture companies to tap into Asia Pacific's potential. Further, less stringent regulatory environment compared to developed regions has encouraged local players to manufacture sutures and medical devices at lower costs for both domestic consumption as well as export purposes. This ensures adequate supply and competitive pricing of sutures in Asia Pacific, which has bolstered its demand. Increasing medical tourism across Asia Pacific is another factor attracting global MedTech giants to expand their sutures business in this fast-developing region.
For instance, in July 2025, Smith+Nephew expanded its Q-FIX All-Suture Anchor portfolio, enhancing fixation strength for orthopedic procedures. The updated system supports soft tissue-to-bone repair with advanced suture technology, offering improved performance in sports medicine and hospital surgeries. This global launch reinforces the company’s leadership in minimally invasive surgical solutions.
In 2025, the U.S. sutures market is thriving due to a high volume of surgical procedures, advanced healthcare infrastructure, and growing adoption of absorbable and antimicrobial sutures. Rising chronic conditions and aging population further fuel demand, while innovation in minimally invasive and robotic surgeries boosts the need for precision suturing solutions across hospitals and clinics.
For instance, in June 2025, OSSIO launched its small OSSIOfiber® Suture Anchors, expanding its portfolio of bio-integrative, metal-free implants for soft tissue fixation. Designed to enhance surgical outcomes without permanent hardware, the new anchors offer high strength and natural bone integration. The launch targets orthopedic and sports medicine procedures, with initial focus on the U.S. market.
In 2025, China's sutures market is booming due to rising surgical procedures, expanding healthcare infrastructure, and increased focus on infection control. Government support for domestic medical innovation, like antibacterial sutures, and growing demand for advanced wound care in urban hospitals are driving rapid adoption. Aging population and chronic diseases further fuel market growth.
For instance, in July 2025, Genesis MedTech introduced China’s first NPMA-approved antibacterial sutures, marking a breakthrough in domestic surgical innovation. These sutures are designed to reduce infection risks and enhance wound healing, aligning with global standards for safer surgical care. The launch strengthens China’s medical device sector and expands access to advanced suture technology across hospitals nationwide.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 4.62 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.5% | 2032 Value Projection: | USD 8.19 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Medtronic Plc, Johnson & Johnson, SMI, Advanced Medical Solutions Group plc, GMD Group (General Medical Disposable), Bentley Healthcare Pvt. Ltd., Lotus Surgicals, Teleflex Incorporated, Sutumed, Lux Sutures, CliniSut, Smith & Nephew Plc, B. Braun Melsungen AG, CONMED Corporation, Unilene, Riverpoint Medical, Unisur Lifecare Pvt. Ltd., Orion Sutures India Pvt Ltd, Dolphin Sutures, Peters Surgical, Meril Life Sciences Pvt. Ltd., and Corza Medical |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The global sutures market has been witnessing significant investments from manufacturers towards expanding their production capacities. Sutures, being an indispensable medical device for wound closure, are in high demand across healthcare settings. These expansions aim to ensure adequate supply to meet the ever-growing demand and to strengthen manufacturers' positions in terms of sutures market share, as competition intensifies globally
The increasing number of surgical procedures is expected to drive the global sutures market growth over the forecast period. The global sutures market has been witnessing steady growth over the past few years owing to a rise in the number of surgical procedures being performed worldwide. Sutures or stitches are an integral part of almost every surgery to effectively close wounds or surgical incisions. As more and more people are opting for various elective and non-elective surgical treatments for different health conditions, the demand for sutures has increased significantly.
Rising research and development activities in the sutures market are fueling advancements in suture materials, coatings, and delivery mechanisms. Manufacturers are investing in bioabsorbable and antimicrobial sutures to enhance healing and reduce infection risks. These innovations align with the growing demand for minimally invasive surgeries and improved patient outcomes. As a result, the sutures market forecast projects robust growth, with technological breakthroughs playing a pivotal role in expanding clinical applications and market penetration. R&D is thus a cornerstone in sustaining competitiveness and meeting evolving surgical needs globally.
To learn more about this report, Download Free Sample
The sutures market value is increasingly led by absorbable sutures. Hospitals favor these materials for their predictable absorption and reduced need for removal. Pre-needled sterilized absorbable sutures alone contributed over 80% of absorbable suture revenue in 2024, reflecting a shift toward efficiency and safety in surgical practice.
Innovation in materials is now a key differentiator. Antimicrobial coatings, next-generation biodegradable fibers, and emerging smart sutures are reshaping the competitive landscape. The market remains fragmented; the top five players hold only ~35.8% of the absorbable segment, allowing specialized firms to challenge incumbents with differentiated products.
North America dominates, with hospitals and clinics driving over 53% of consumption, but reliance on developed markets creates exposure to reimbursement and policy pressures. Strategic partnerships and platform-based product development are essential for firms aiming to balance scale with innovation.
The market is evolving from commodity consumables to a high-innovation, patient-outcome-focused segment. Firms that integrate advanced materials with scalable offerings are positioned to lead the next wave of surgical innovation.
Share
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
